Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000063585

Apexbio Technology LLC Decernotinib(VX-509) 944842-54-0 10mM (in 1mL DMSO)
SDP

Supplier:  Apexbio Technology LLC B59295.1

Encompass_Preferred

Decernotinib (VX-509) is an orally bioavailable inhibitor targeting Janus kinase 3 (JAK3) with additional inhibitory activities toward JAK1 JAK2 and TYK2 (Ki values JAK3 2 nM JAK1 11 nM JAK2 13 nM TYK2 11 nM) Janus kinases are intracellular tyrosine kinases critical for cytokine-mediated signal transmission involved notably in immune cell activation and inflammatory responses By inhibiting JAK-mediated STAT5 phosphorylation VX-509 modulates cytokine-dependent lymphocyte proliferation and activation This compound has been employed in preclinical models exploring therapeutic potential in autoimmune conditions and inflammatory disorders such as rheumatoid arthritis

Catalog No. 50-000-63585


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.